MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria

被引:0
作者
Emilia Persson
Christian Jamtheim Gustafsson
Petra Ambolt
Silke Engelholm
Sofie Ceberg
Sven Bäck
Lars E. Olsson
Adalsteinn Gunnlaugsson
机构
[1] Skåne University Hospital,Radiation Physics, Department of Hematology, Oncology, and Radiation Physics
[2] Lund University,Department of Translational Medicine, Medical Radiation Physics
[3] Lund University,Department of Medical Radiation Physics
来源
Radiation Oncology | / 15卷
关键词
MRI only; Prostate; Synthetic CT; Clinical implementation; Prospective; Acceptance criteria;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 150 条
[1]  
Salembier C(2018)ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer Radiother Oncol 127 49-61
[2]  
Villeirs G(2015)Radiotherapy planning using MRI Phys Med Biol 60 R323-R361
[3]  
De Bari B(2016)Comparison of manual and automatic MR-CT registration for radiotherapy of prostate cancer J Appl Clin Med Phys 17 294-303
[4]  
Hoskin P(2009)Systematisation of spatial uncertainties for comparison between a MR and a CT-based radiotherapy workflow for prostate treatments Radiat Oncol 4 54-482
[5]  
Pieters BR(2005)Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate Med Phys 32 473-94
[6]  
Van Vulpen M(2019)Precision of T2 TSE MRI-CT-image fusions based on gold fiducials and repetitive T2 TSE MRI-MRI-fusions for adaptive IGRT of prostate cancer by using phantom and patient data Acta Oncol 58 88-1060
[7]  
Schmidt MA(2016)Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial Lancet Oncol 17 1047-395
[8]  
Payne GS(2019)Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial Lancet. 394 385-217
[9]  
Korsager AS(2018)MRI-only treatment planning: benefits and challenges Phys Med Biol 63 05TR1-907
[10]  
Carl J(2017)A review of substitute CT generation for MRI-only radiation therapy Radiat Oncol 12 28-791